Seattle Genetics (SGEN) Reports In-Line Q1 EPS

April 27, 2017 4:46 PM EDT

Seattle Genetics (NASDAQ: SGEN) reported Q1 EPS of ($0.42), in-line with the analyst estimate of ($0.42). Revenue for the quarter came in at $109.1 million versus the consensus estimate of $103.23 million.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings